287 related articles for article (PubMed ID: 28553074)
1. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.
Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G
Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.
Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H
Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686
[TBL] [Abstract][Full Text] [Related]
5. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G
J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer.
Wu J; Wu S; Shi L; Zhang S; Ren J; Yao S; Yun D; Huang L; Wang J; Li W; Wu X; Qiu P; Liang G
Eur J Med Chem; 2017 Jan; 125():1321-1331. PubMed ID: 27886548
[TBL] [Abstract][Full Text] [Related]
7. Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines.
Bertazza L; Barollo S; Mari ME; Faccio I; Zorzan M; Redaelli M; Rubin B; Armanini D; Mian C; Pezzani R
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212829
[TBL] [Abstract][Full Text] [Related]
8. Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.
Sagar S; Singh S; Mallareddy JR; Sonawane YA; Napoleon JV; Rana S; Contreras JI; Rajesh C; Ezell EL; Kizhake S; Garrison JC; Radhakrishnan P; Natarajan A
Eur J Med Chem; 2021 Oct; 222():113579. PubMed ID: 34098465
[TBL] [Abstract][Full Text] [Related]
9. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
[TBL] [Abstract][Full Text] [Related]
10. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
[TBL] [Abstract][Full Text] [Related]
11. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
12. Studies on gambogic acid (IV): Exploring structure-activity relationship with IκB kinase-beta (IKKβ).
Sun H; Chen F; Wang X; Liu Z; Yang Q; Zhang X; Zhu J; Qiang L; Guo Q; You Q
Eur J Med Chem; 2012 May; 51():110-23. PubMed ID: 22472167
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
[TBL] [Abstract][Full Text] [Related]
14. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
16. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity of new 4-arylidene curcumin analogues and their multi-functions in inhibition of both NF-κB and Akt signalling.
Zuo Y; Huang J; Zhou B; Wang S; Shao W; Zhu C; Lin L; Wen G; Wang H; Du J; Bu X
Eur J Med Chem; 2012 Sep; 55():346-57. PubMed ID: 22889562
[TBL] [Abstract][Full Text] [Related]
18. Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.
Zhu S; Moore TW; Lin X; Morii N; Mancini A; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G; Chen ZG; Sun A; Fu H; Khuri FR; Shin DM; Snyder JP; Shoji M
Integr Biol (Camb); 2012 Jun; 4(6):633-40. PubMed ID: 22532032
[TBL] [Abstract][Full Text] [Related]
19. W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Xia Y; Weng B; Wang Z; Kang Y; Shi L; Huang G; Ying S; Du X; Chen Q; Jin R; Wu J; Liang G
Tumour Biol; 2016 Apr; 37(4):4791-801. PubMed ID: 26520440
[TBL] [Abstract][Full Text] [Related]
20. Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences.
Patil KR; Mohapatra P; Patel HM; Goyal SN; Ojha S; Kundu CN; Patil CR
PLoS One; 2015; 10(5):e0125709. PubMed ID: 25938234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
